Cargando…
Identification of Putative Non-Substrate-Based XT-I Inhibitors by Natural Product Library Screening
Fibroproliferative diseases are characterized by excessive accumulation of extracellular matrix (ECM) components leading to organ dysfunction. This process is characterized by an increase in myofibroblast content and enzyme activity of xylosyltransferase-I (XT-I), the initial enzyme in proteoglycan...
Autores principales: | Ly, Thanh-Diep, Kleine, Anika, Fischer, Bastian, Schmidt, Vanessa, Hendig, Doris, Kuhn, Joachim, Knabbe, Cornelius, Faust, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589200/ https://www.ncbi.nlm.nih.gov/pubmed/33096778 http://dx.doi.org/10.3390/biom10101467 |
Ejemplares similares
-
Activin A-Mediated Regulation of XT-I in Human Skin Fibroblasts
por: Ly, Thanh-Diep, et al.
Publicado: (2020) -
The Impact of Inflammatory Stimuli on Xylosyltransferase-I Regulation in Primary Human Dermal Fibroblasts
por: Ly, Thanh-Diep, et al.
Publicado: (2022) -
microRNA-29b mediates fibrotic induction of human xylosyltransferase-I in human dermal fibroblasts via the Sp1 pathway
por: Riedel, Lara, et al.
Publicado: (2018) -
First Characterization of Human Dermal Fibroblasts Showing a Decreased Xylosyltransferase-I Expression Induced by the CRISPR/Cas9 System
por: Fischer, Bastian, et al.
Publicado: (2022) -
Human Xylosyltransferase I—An Important Linker between Acute Senescence and Fibrogenesis
por: Schmidt, Vanessa, et al.
Publicado: (2023)